Respiratory extracorporeal membrane oxygenation for severe sepsis and septic shock in adults : a propensity score analysis in a multicenter retrospective observational study

Takauji, Shuhei; Hayakawa, Mineji; Ono, Kota et al.

Acute Medicine & Surgery, 2017, 4(4), 408-417

Permalink : https://hdl.handle.net/2115/67629

このアイテムのアクセス数:979件（2026-08-08 19:21 集計）

閲覧可能ファイル 

ファイル フォーマット サイズ 閲覧回数 説明
Takauji_et_al-2017-Acute_Medicine_and_Surgery pdf 243 KB 699

論文情報

ファイル出力 EndNote Basic出力 Mendeley出力

アクセス権
open access
URI
https://hdl.handle.net/2115/67629
タイトル
Respiratory extracorporeal membrane oxygenation for severe sepsis and septic shock in adults : a propensity score analysis in a multicenter retrospective observational study
著者
Takauji, Shuhei ; Hayakawa, Mineji ; Ono, Kota ; Makise, Hiroshi
著者名
Takauji, Shuhei
e-Rad_Researcher
10374282
著者名
Hayakawa, Mineji
著者名
Ono, Kota
著者名
Makise, Hiroshi
言語
英語
キーワード
extracorporeal membrane oxygenation
infection
mortality
respiratory failure
sepsis
発行日
2017-10
出版者
Wiley
収録物名
Acute Medicine & Surgery
巻(号)
4(4)
ページ
408-417
抄録
Aim: This multicenter retrospective observational study aimed to evaluate the efficacy of extracorporeal membrane oxygenation (ECMO) support for septic patients with severe respiratory failure using propensity score analyses. Methods: The data of severe sepsis patients from 42 intensive care units between January 2011 and December 2013 were retrospectively collected. Propensity score matching analyses were undertaken for severe respiratory failure patients with/without veno-venous ECMO support. The main outcome was in-hospital all-cause mortality. Results: Of 3195 patients with severe sepsis, 570 had severe respiratory failure. Forty patients in the ECMO group were matched with 150 patients in the control group. A survival time analysis revealed no difference in the in-hospital survival (hazard ratio, 0.854; 95% confidence interval, 0.531-1.373; P = 0.515). Two-hundred and eighty-five patients had severe respiratory failure induced by lung infection. Twenty-five ECMO group patients were matched with 89 patients in the control group. In the ECMO group, the survival time was longer than in the control group (hazard ratio, 0.498; 95% confidence interval, 0.279-0.889; P = 0.018). The number of renal replacement therapy- and vasopressor-free days improved. The ECMO group received more red blood cells transfused than the control group, but there was no significant difference in the rate of severe bleeding complications between the groups. Conclusions: There was no difference in the in-hospital survival between the ECMO group and control group among overall septic patients with severe respiratory failure. However, in sepsis patients with severe respiratory failure induced by lung infection, ECMO support may improve their survival time.
資源タイプ
学術雑誌論文
出版タイプ
Version of Record
権利情報
Creative Commons Attribution-NonCommercial 4.0 International
PISSN
2052-8817
関連情報 (isIdenticalTo)
出版社版DOI
https://doi.org/10.1002/ams2.296